00983nas a2200217   4500000000100000008004100001260001300042653001100055653001100066653002500077653000900102653002700111653001700138653001600155100001300171245005600184300000900240490000700249520049500256022001400751       1989                            d  c1989 Mar10aFemale10aHumans10aLeprosy, Tuberculoid10aMale10aPigmentation Disorders10aPUVA Therapy10aSex Factors1 aAmar A K00aPsoralene in repigmentation of tuberculoid leprosy.  a9-120 v343 a<p>Photoactivated psoralens were studied in sixty cases of tuberculoid leprosy for the repigmentation of hypopigmented macules. It was observed that in 42 (70%) cases there was significant repigmentation within 6 months of therapy; in 5 (8.33%) cases there was mild to moderate repigmentation and in 13 (22.64%) cases, there was no change. No significant untoward effects of drug were encountered, except in four patients (6.66%), who developed, marked erythema and eczematous reaction.</p>  a0019-5154